SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022351
Filing Date
2020-05-07
Accepted
2020-05-07 07:01:40
Documents
74
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q syrs-10q_20200331.htm 10-Q 1663848
2 EX-31.1 syrs-ex311_48.htm EX-31.1 17648
3 EX-31.2 syrs-ex312_46.htm EX-31.2 17639
4 EX-32.1 syrs-ex321_47.htm EX-32.1 5964
5 EX-32.2 syrs-ex322_45.htm EX-32.2 6071
  Complete submission text file 0001564590-20-022351.txt   7218674

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT syrs-20200331.xml EX-101.INS 1571589
7 XBRL TAXONOMY EXTENSION SCHEMA syrs-20200331.xsd EX-101.SCH 61605
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syrs-20200331_cal.xml EX-101.CAL 60384
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syrs-20200331_def.xml EX-101.DEF 202591
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE syrs-20200331_lab.xml EX-101.LAB 485022
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syrs-20200331_pre.xml EX-101.PRE 383737
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37813 | Film No.: 20854506
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences